Latest Production News

Hydralyte USA has completed its Rights Issue by placing 5 million shortfall shares, raising a total of $608,878 before costs. The move finalizes the company’s recent capital raising efforts under full regulatory compliance.

Renascor Resources has secured an option agreement for land near its Siviour graphite deposit, finalising a critical step in supporting its upstream mining and processing operations. This move advances the company’s Battery Anode Material project readiness with accommodation planned for construction and operational staff.

Yowie Group has decided not to proceed with its planned takeover bid for Keybridge Capital after a key condition was triggered, signaling a strategic retreat.

GTi Energy has raised $2.5 million from the first tranche of a $4.5 million placement to fund drilling at its Lo Herma uranium project, with key permits expected in August and a strategic investment from Snow Lake Energy pending shareholder approval.

Brightstar Resources has launched its second phase of drilling at the Yunndaga deposit, aiming to expand and refine its gold resource as part of a fast-tracked development plan at the Menzies Hub.

Yowie Group has appointed Jesse Hamilton as its new Company Secretary, following the resignation of John Patton. The company also confirmed the automatic termination of executive roles held by former directors Nicholas Bolton and John Patton.

Manuka Resources has boosted the net present value of its Cobar Basin silver and gold project to A$153 million, driven by higher commodity prices, while advancing financing talks and exploring a Mt Boppy open pit cut-back to enhance production.

Peninsula Energy has locked in a $15 million debt facility from Davidson Kempner to advance commissioning at its Lance uranium project and support an upcoming equity raise. The funding aims to sustain momentum towards production resumption and ASX relisting.

Victory Metals has significantly enhanced its North Stanmore resource with Gallium inclusion and secured major financing commitments exceeding US$200 million, positioning itself as a strategic supplier amid global rare earths tensions.

Imricor Medical Systems has secured key European regulatory approvals for its second-generation NorthStar system and initiated its commercial launch, while US FDA submissions progress amid some delays.

Osmond Resources has significantly expanded its Orion EU Critical Minerals Project by 160%, with promising assay results and a planned drilling program to confirm mineral continuity. The company is positioning itself to benefit from strong EU demand for rare earths, titanium, and silicon metals.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.